FDA approves first novel schizophrenia med in decades

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Approval of Bristol Myers Drug Makes It the First Novel Schizophrenia Med in Decades Bristol Myers Squibb's Cobenfy treats schizophrenia by going after a different target than currently available antipsychotic drugs, which is intended to offer better efficacy and safety. The drug came from the pharma giant's $14 billion acquisition of Karuna Therapeutics. Sponsored Attend the Discovery Critical Care Innovation Incubator Presented by Society of Critical Care Medicine Attend the Discovery Critical Care Innovation Incubator on February 22, 2025, in Orlando, Florida, and ignite impactful change! Designed to foster collaboration among leading minds across diverse disciplines, this event will explore emerging innovations, spark partnerships, and fuel inspiration. Register and find more details at sccm.org/innovation.

Featured News

AI Holds Promise, But Concerns Around Costs and Data Remain The new generation of healthcare AI innovation is promising, but there are some problems that remain when it comes to AI, such as data generalization and the high cost of adopting new tools, pointed out Dr. Arash Harzand. Pomelo Care Acquires The Doula Network to Link Patients with Community-Based Doulas Pomelo Care recently acquired The Doula Network. Through the acquisition, Pomelo's patients can now be matched with a community-based doula. How AI Can Help Hospitals Overcome Patient Flow Barriers Artificial intelligence (AI) holds potential to forecast and predict where hospital leaders should direct limited resources such as clinicians, staff, and beds to improve operational efficiency and drive better patient outcomes.  Why Accessible, Worldwide Biomanufacturing Solutions are Paramount Precision medicine relies on understanding how differences affect drug response. Researchers can develop more precise treatments that are effective for more patients when prioritizing diversity.

Resources

MedCity Pivot Podcast: How AI Can Help in Cancer Dr. Timothy Showalter talks about how AI can be a powerful force in recommending treatment for cancer patients. He is Artera's chief medical officer and the company has built a digital pathology tool for prostate cancer patients. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe